Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ·Healthcare·Biotechnology
$0.53
—
Mkt Cap $6.85M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$0.53
—
Mkt Cap $6.85M
Buy
2
Hold
1
Sell
0
Price Target (— analysts)
—
Range — – —